Science Explorer Interactive view Map
Company · Stamford · United States

Loxo Oncology at Lilly (United States)

loxooncology.comROR OpenAlex
Research works
77
▲ 307% vs 2013–17
Citations
1.9k
24.9 per fractional work
Top-10% rate
27.7%
record average 16.5%
Open access
56%
world 28%

Not ranked overall: Loxo Oncology at Lilly (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.21× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.04× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 4.44× its world share, 1 worksImmunology and Micro…Neuroscience: 0.03× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.53× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.33× its world share, 1 worksChemistryComputer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 0.46× its world share, 1 worksEnvironmental SciencePhysics and Astronomy: 0.04× its world share, 0 worksPhysics and AstronomyMedicine: 2.90× its world share, 18 worksMedicineArts and Humanities: 0.18× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 1.63× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.22× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.5×. Every wedge is a field page.

Who are the top researchers at Loxo Oncology at Lilly (United States)?

Ranked on the composite score, S. Michael Rothenberg lead among researchers whose main affiliation is Loxo Oncology at Lilly (United States).

  1. 1 S. Michael Rothenberg United States · #1,484,105 worldwide 16 citations · 27 works
All ranked researchers at Loxo Oncology at Lilly (United States)

Which keywords describe research at Loxo Oncology at Lilly (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Targeted Therapy, Cancer, Chemotherapy and Lymphoma.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Rituximab5▲ 109×2 topics
  2. Prognostic Factors5▲ 35×8 topics
  3. Chronic Lymphocytic Leukemia4▲ 268×1 topic
  4. Genomic Aberrations4▲ 268×1 topic
  5. Cancer2▲ 5.8×13 topics
  6. Targeted Therapy2▲ 33×4 topics
  7. Chemotherapy2▲ 9.6×12 topics
  8. Lymphoma2▲ 40×2 topics
  9. Breast Cancer2▲ 26×5 topics
  10. Clinical Trials2▲ 9.2×4 topics
  11. Immunotherapy2▲ 8.7×11 topics
  12. PET Imaging2▲ 32×5 topics
  13. Genomic Profiling2▲ 46×2 topics
  14. ALK Inhibitors1▲ 72×1 topic
  15. Classification1▲ 9.6×1 topic
  16. EGFR Mutations1▲ 72×1 topic
  17. Molecular Profiling1▲ 44×1 topic
  18. Cancer Therapy1▲ 7.3×11 topics
  19. Metastatic Breast Cancer1▲ 74×2 topics
  20. Biomarkers1▲ 5.3×5 topics
  21. Signaling1▲ 61×3 topics
  22. Quality of Life1▲ 2.3×4 topics

Which research topics does Loxo Oncology at Lilly (United States) publish most on?

By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations, Lymphoma Diagnosis and Treatment and Advanced Breast Cancer Therapies.

Chronic Lymphocytic Leuk…4Chronic Lymphocytic Leukemia Research: 4 fractional worksLung Cancer Treatments a…1Lung Cancer Treatments and Mutations: 1 fractional worksLymphoma Diagnosis and T…1Lymphoma Diagnosis and Treatment: 1 fractional worksAdvanced Breast Cancer Therapies: 1 fractional worksChronic Myeloid Leukemia Treatments: 1 fractional worksCAR-T cell therapy research: 1 fractional worksPI3K/AKT/mTOR signaling in cancer: 1 fractional worksRNA modifications and cancer: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksCancer Genomics and Diagnostics: 0 fractional works
GeneticsPulmonary and Respiratory MedicinePathology and Forensic MedicineHematology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 4 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  3. 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  5. 5 Chronic Myeloid Leukemia Treatments Hematology 1 works
  6. 6 CAR-T cell therapy research Oncology 1 works
  7. 7 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
  8. 8 RNA modifications and cancer Molecular Biology 1 works
  9. 9 Cancer Treatment and Pharmacology Oncology 1 works
  10. 10 Cancer Genomics and Diagnostics Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.0%not open44.0%

World: 28% of research is openly available.

with international co-authors36.8%domestic only63.2%

World: 19% is written across borders.

How has Loxo Oncology at Lilly (United States)'s research output changed?

Output in 2018–2022 was 307% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Stamford

All research institutions in Stamford

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.